JASMINE Trial Demonstrates Prolacta's Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan's Renowned Low NEC Rate

Better Growth Has Been Associated with Improved Long-Term Neurodevelopment Prolacta's Human Milk-Based Fortifiers Proved Safe and Effective Alternative to Japan's Practice of Delaying Cow Milk-Based Fortifiers to Avoid Complications JASMINE Data Used by Japan's Ministry of Health, Labour,...